Back

BUD13 as a novel mediator of vascular endothelial dysfunction associated with type 2 diabetes

17 April 2026 (08:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Young Investigators Award Vascular Diseases Delegates Premium Access Frontiers in CardioVascular Biomedicine 2026 Council on Basic Cardiovascular Science

About the speaker

Photo
Doctor Alvaro Santana Garrido

Karolinska Institute, Stockholm (Sweden)

5 More presentations in this session

Presentation thumbnail
Atrial tissue engineering using conditionally immortalized human myocytes: establishing matured and geometrically defined 3D models of atrial arrhythmias
Mr A. Nobacht (Leiden, NL)
Abstract Slides
Presentation thumbnail
The novel ErbB4 agonist JK07 modulates gene expression in key cardiac cells. insights from single-nuclei transcriptomics in a murine heart failure model
Miss C. Civati (Antwerp, BE)
Abstract Slides
Presentation thumbnail
Inhibition of dysregulated il-8-cxcr1 paracrine cellular crosstalk reverses cardiac hypertrophy and fibrosis in noonan syndrome
Mr F. Koitka (Goettingen, DE)
Abstract Slides
Presentation thumbnail
CSF2-driven myeloid reprogramming onnects metabolic stress to pulmonary vascular remodeling in HFpEF
Ms V. Masciovecchio (Zurich, CH)
Abstract Slides
Presentation thumbnail
Exploring cardiomyocytes-endothelial cell communication to promote cardiac revascularization and regeneration
Mrs F. Longo (Trieste, IT)
Abstract Slides

Access the full session

Session thumbnail
Young Investigators Award

The Event

Event poster

Frontiers in CardioVascular Biomedicine 2026

17 April - 19 April 2026
You may be interested in
thumbnail
Congress Presentation
Preclinical heart failure in Circulation
thumbnail
Congress Session
ESC William Harvey Lecture in Basic Science
thumbnail
Congress Presentation
State-of-the-art lecture on vascular (dys)function in the failing heart

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources